Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSTINCT: IVIG for Necrotizing Soft Tissue Infections
NCT02111161Phase 2Completed
- Sponsor
- Anders Perner
- Start
- Apr 2014
- Primary completion
- Sep 2016
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of polyvalent human immunoglobulin in necrotizing soft tissue infection (NSTI), sponsored by Anders Perner. Started Apr 2014; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
necrotizing soft tissue infection (NSTI)
Beyond the preview
Go deeper on NCT02111161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111161.